Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions

scientific article published on 01 May 1976

Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CPT1976195PART1508
P698PubMed publication ID776488

P2093author name stringJ. M. Strong
A. J. Atkinson
J. S. Dutcher
W. K. Lee
R. F. Kehoe
P433issue5 Pt 1
P407language of work or nameEnglishQ1860
P304page(s)508-514
P577publication date1976-05-01
P1433published inClinical Pharmacology & TherapeuticsQ1101529
P1476titleAntiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions
P478volume19

Reverse relations

cites work (P2860)
Q28260649Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias
Q52706260Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Q46196153Antiarrhythmic potency of procainamide and N-acetylprocainamide in rabbits
Q28262289Clinical Pharmacokinetics of N-acetylprocainamide
Q39720665Clinical Pharmacokinetics of Procainamide
Q41690934Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype
Q72626194Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide
Q41064424Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide
Q44261205Drug Metabolism and Active Drug Metabolites in Renal Failure
Q40325635Drug metabolites in renal failure: pharmacokinetic and clinical implications
Q39621411Effect of active drug metabolites on plasma level-response correlations
Q71397213Effect of procainamide on left ventricular performance in patients with primary myocardial disease
Q72633084Electrophysiologic effects of N-acetylprocainamide in human beings
Q89869342Elucidation of the pathophysiology of intradialytic muscle cramps: pharmacokinetics applied to translational research
Q67353778Pharmacokinetic approach to intravenous procainamide therapy
Q28329448Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure
Q66704847Procainamide, acetylprocainamide, and drug-induced lupus erythematosus
Q66704846Renal effects of tolazoline in rabbits
Q43509787Serum Levels and Electrophysiological Effects of N-Acetylprocainamide as Compared with Procainamide in the Dog Heart in situ
Q67041226Serum Procainamide Levels As Therapeutic Guides
Q72722386Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide
Q39533089Significance of the acetylation phenotype and the therapeutic effect of procainamide
Q40282215The pharmacological role of the kidney
Q40327652Therapeutic drug monitoring of antiarrhythmic agents

Search more.